02 May 2003
Inhibitors of poly(ADP-ribose) polymerase activity as interventions against renal ischemia/reperfusion injury and acute renal failure
P. Chatterjee, M. McDonald, M. Threadgill, C. ThiemermannMed Sci Monit 2003; 9(1): 10-0 :: ID: 15056
Abstract
Excessive activation of PARP contributes to the renal dysfunction and injury caused by reactive oxygen species (ROS), nitric oxide and peroxynitrite [1]. However, most inhibitors of PARP activity are either weak inhibitors (e.g. 3-aminobenzamide) or are soluble in dimethyl sulphoxide (e.g. 5-dihydroxyisoquinoline). We therefore investigated the effects of the water-soluble PARP inhibitor, 5-aminoisoquinolinone (5-AIQ), on the (i) renal dysfunction caused by 45 min ischaemia followed by 6 h reperfusion (I/R) in vivo and (ii) cytotoxicity caused by exposure of rat proximal tubular (PT) cells to oxidative stress (1 mM H2O2 for 4 h) in vitro.Renal I/R produced a significant increase in serum creatinine levels (indicating renal dysfunction) which was reduced significantly by 5-AIQ (Table 1). Incubation of rat PT cells with H2O2 increased LDH significantly (indicating renal cytotoxicity) (Table 2), however, incubation with H2O2 and 5-AIQ produced a significant reduction in LDH release (Table 2).Thus we propose that PARP inhibitors may be useful in conditions which involve renal ischaemia and reperfusion (e.g. renal transplantation).References: 1.Chatterjee PK, Thiemermann C: Poly(ADP-ribose) polymerase inhibitors and acute renal failure. In: Zhang J (ed.): Therapeutic Utilities of PARP Inhibitors. CRC Press; Boca Raton, 2002, pp. 149-168
Keywords: renal, Kidney, proximal tubular cells, poly(ADP-ribose) polymerase, poly(ADP-ribose) polymerase inhibitor, 5-aminoisoquinolinone, 5-dihydroxyisoquinolinoline
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952